GB2109231A - Medicament containing progesterone - Google Patents
Medicament containing progesterone Download PDFInfo
- Publication number
- GB2109231A GB2109231A GB08229804A GB8229804A GB2109231A GB 2109231 A GB2109231 A GB 2109231A GB 08229804 A GB08229804 A GB 08229804A GB 8229804 A GB8229804 A GB 8229804A GB 2109231 A GB2109231 A GB 2109231A
- Authority
- GB
- United Kingdom
- Prior art keywords
- progesterone
- group
- mammary
- percutaneous
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 title claims abstract description 80
- 229960003387 progesterone Drugs 0.000 title claims abstract description 40
- 239000000186 progesterone Substances 0.000 title claims abstract description 40
- 239000003814 drug Substances 0.000 title claims abstract description 19
- 208000006662 Mastodynia Diseases 0.000 claims abstract description 19
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 7
- 208000035475 disorder Diseases 0.000 claims abstract description 7
- 206010006298 Breast pain Diseases 0.000 claims description 8
- 230000001476 alcoholic effect Effects 0.000 claims description 6
- 210000000481 breast Anatomy 0.000 claims description 6
- 230000003054 hormonal effect Effects 0.000 claims description 6
- 230000001225 therapeutic effect Effects 0.000 claims description 6
- 210000004291 uterus Anatomy 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 4
- 230000008034 disappearance Effects 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 4
- 239000000262 estrogen Substances 0.000 claims description 4
- 230000007170 pathology Effects 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 229920000642 polymer Polymers 0.000 claims description 4
- 150000003431 steroids Chemical class 0.000 claims description 4
- 239000008213 purified water Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 206010003694 Atrophy Diseases 0.000 claims description 2
- 208000012641 Pigmentation disease Diseases 0.000 claims description 2
- 201000004471 adenofibroma Diseases 0.000 claims description 2
- 230000000172 allergic effect Effects 0.000 claims description 2
- 208000010668 atopic eczema Diseases 0.000 claims description 2
- 230000037444 atrophy Effects 0.000 claims description 2
- 230000002238 attenuated effect Effects 0.000 claims description 2
- 230000004888 barrier function Effects 0.000 claims description 2
- 230000008901 benefit Effects 0.000 claims description 2
- 230000004856 capillary permeability Effects 0.000 claims description 2
- 230000001413 cellular effect Effects 0.000 claims description 2
- 208000031513 cyst Diseases 0.000 claims description 2
- 230000006735 deficit Effects 0.000 claims description 2
- 230000004069 differentiation Effects 0.000 claims description 2
- 230000001079 digestive effect Effects 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- 230000002440 hepatic effect Effects 0.000 claims description 2
- 230000006872 improvement Effects 0.000 claims description 2
- 210000005075 mammary gland Anatomy 0.000 claims description 2
- 230000005906 menstruation Effects 0.000 claims description 2
- 230000000877 morphologic effect Effects 0.000 claims description 2
- 210000004877 mucosa Anatomy 0.000 claims description 2
- 230000027758 ovulation cycle Effects 0.000 claims description 2
- 230000002688 persistence Effects 0.000 claims description 2
- 230000019612 pigmentation Effects 0.000 claims description 2
- 230000002265 prevention Effects 0.000 claims description 2
- 230000008961 swelling Effects 0.000 claims description 2
- 238000002560 therapeutic procedure Methods 0.000 claims description 2
- 230000002792 vascular Effects 0.000 claims description 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8120034A FR2515041A1 (fr) | 1981-10-26 | 1981-10-26 | Medicament a base de progesterone pour le traitement des affections mammaires |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB2109231A true GB2109231A (en) | 1983-06-02 |
Family
ID=9263374
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB08229804A Withdrawn GB2109231A (en) | 1981-10-26 | 1982-10-19 | Medicament containing progesterone |
Country Status (3)
| Country | Link |
|---|---|
| DE (1) | DE3238984A1 (enrdf_load_stackoverflow) |
| FR (1) | FR2515041A1 (enrdf_load_stackoverflow) |
| GB (1) | GB2109231A (enrdf_load_stackoverflow) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0667826B2 (ja) | 1984-01-20 | 1994-08-31 | モベ−ジヤ−ビス，ピエ−ル | 経皮投与用抗エストロゲン薬剤 |
| US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
| US6670350B1 (en) * | 1999-02-18 | 2003-12-30 | Jenapharm Gmbh & Co. Kg | Method of administering dienogest in high dosages to reduce the body of the breast and pharmaceutical composition for same |
| US6696433B2 (en) | 1996-07-22 | 2004-02-24 | Renovo Limited | Use of sex steroids function modulators to treat wounds and fibrotic disorders |
| DE102008064534A1 (de) * | 2008-12-29 | 2010-07-15 | Reimers, Simon | Mobil-Aufrecht-Fahr-System |
| US8466138B2 (en) | 2005-10-12 | 2013-06-18 | Unimed Pharmaceuticals, Llc | Testosterone gel and method of use |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5744463A (en) * | 1996-06-03 | 1998-04-28 | Bair; Glenn O. | Treatment of side effects of progestins and progesterone analogues used for birth control |
| US6056972A (en) * | 1997-02-26 | 2000-05-02 | Dimera, Llc | Method for reducing coronary artery reactivity |
| US7968532B2 (en) | 2003-12-15 | 2011-06-28 | Besins Healthcare Luxembourg | Treatment of gynecomastia with 4-hydroxy tamoxifen |
| US7507769B2 (en) | 2004-03-22 | 2009-03-24 | Laboratoires Besins International | Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| DK1748770T3 (da) * | 2004-03-22 | 2008-08-04 | Besins Int Lab | Behandling og forebyggelse af benign brystsygdom med 4-hydroxy-tamoxifen |
| EP1579856A1 (en) * | 2004-03-22 | 2005-09-28 | Laboratoires Besins International | Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1047518A (en) * | 1963-06-11 | 1966-11-02 | Glaxo Lab Ltd | 17ª-monoesters of 11,17,21-trihydroxy steroid compounds |
| US4136173A (en) * | 1977-01-31 | 1979-01-23 | American Home Products Corp. | Mixed xanthan gum and locust beam gum therapeutic compositions |
| DE2964471D1 (en) * | 1979-06-08 | 1983-02-17 | Toko Yakuhin Kogyo Kk | Creamy preparation containing steroid and process for the preparation thereof |
-
1981
- 1981-10-26 FR FR8120034A patent/FR2515041A1/fr active Granted
-
1982
- 1982-10-19 GB GB08229804A patent/GB2109231A/en not_active Withdrawn
- 1982-10-21 DE DE19823238984 patent/DE3238984A1/de active Granted
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0667826B2 (ja) | 1984-01-20 | 1994-08-31 | モベ−ジヤ−ビス，ピエ−ル | 経皮投与用抗エストロゲン薬剤 |
| US6696433B2 (en) | 1996-07-22 | 2004-02-24 | Renovo Limited | Use of sex steroids function modulators to treat wounds and fibrotic disorders |
| US6670350B1 (en) * | 1999-02-18 | 2003-12-30 | Jenapharm Gmbh & Co. Kg | Method of administering dienogest in high dosages to reduce the body of the breast and pharmaceutical composition for same |
| US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
| US9132089B2 (en) | 2000-08-30 | 2015-09-15 | Besins Healthcare Inc. | Pharmaceutical composition and method for treating hypogonadism |
| US9125816B2 (en) | 2000-08-30 | 2015-09-08 | Besins Healthcare Inc. | Pharmaceutical composition and method for treating hypogonadism |
| US8466136B2 (en) | 2005-10-12 | 2013-06-18 | Unimed Pharmaceuticals, Llc | Testosterone gel and method of use |
| US8466137B2 (en) | 2005-10-12 | 2013-06-18 | Unimed Pharmaceuticals, Llc | Testosterone gel and method of use |
| US8486925B2 (en) | 2005-10-12 | 2013-07-16 | Unimed Pharmaceuticals, Llc | Testosterone gel and method of use |
| US8729057B2 (en) | 2005-10-12 | 2014-05-20 | Unimed Pharmaeuticals, LLC | Testosterone gel and method of use |
| US8741881B2 (en) | 2005-10-12 | 2014-06-03 | Unimed Pharmaceuticals, Llc | Testosterone gel and method of use |
| US8754070B2 (en) | 2005-10-12 | 2014-06-17 | Unimed Pharmaceuticals, Llc | Testosterone gel and method of use |
| US8759329B2 (en) | 2005-10-12 | 2014-06-24 | Unimed Pharmaceuticals, Llc | Testosterone gel and method of use |
| US8466138B2 (en) | 2005-10-12 | 2013-06-18 | Unimed Pharmaceuticals, Llc | Testosterone gel and method of use |
| DE102008064534A1 (de) * | 2008-12-29 | 2010-07-15 | Reimers, Simon | Mobil-Aufrecht-Fahr-System |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2515041A1 (fr) | 1983-04-29 |
| DE3238984A1 (de) | 1983-05-05 |
| FR2515041B3 (enrdf_load_stackoverflow) | 1984-06-15 |
| DE3238984C2 (enrdf_load_stackoverflow) | 1991-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2646667C (en) | Methods of treating hot flashes with formulations for transdermal or transmucosal application | |
| US4678772A (en) | Compositions containing glycyrrhizin | |
| CA1326443C (en) | Hemorrhoidal, other compositions and methods of treatment | |
| GB2109231A (en) | Medicament containing progesterone | |
| PL209943B1 (pl) | Zastosowanie moksifloksacyny stanowiącej kwas 1-cyklopropylo-6-fluoro-1,4-dihydro-8-metoksy-7-[(4aS,7aS)-oktahydro-6H-pirolo [3,4-b]pirydyn-6-ylo]-4-okso-3-chinolino-karboksylowy | |
| US5371107A (en) | Use of ascorbic acid in the genital area and corresponding medicinal preparations | |
| Ingemanson | Legal abortion by extra-amniotic instillation of Rivanol in combination with rubber catheter insertion into the uterus after the twelfth week of pregnancy | |
| GB2167296A (en) | Topical pharmaceutical compositions containing glycyrrhizin | |
| JP2954366B2 (ja) | 活性成分としてクロラムフェニコール、ゲンタマイシンおよびナイスタチンを含有する、炎症性皮膚疾患の局所治療のための配合製剤 | |
| ES2880437T3 (es) | Nuevas composiciones tópicas que comprenden ácido úsnico y su uso terapéutico | |
| US4302452A (en) | Use of derivatives of 6α-methylprednisolone as an antiemetic | |
| Günther | Topical administration of vitamin A acid (retinoic acid) in palmar keratoses: callosities, hyperkeratotic eczema, hypertrophic lichen planus, pityriasis rubra pilaris | |
| JP7331149B2 (ja) | 直腸および局所投与のためのゲル | |
| JP3507515B2 (ja) | エストリオールの高血中濃度が得られる軟膏剤 | |
| US3894153A (en) | Method of medical treatment of asthma | |
| US4105794A (en) | Process of mitigating cholelithiasis | |
| CN116265023B (zh) | 一种预防和/或治疗耳部感染的药物组合物及其制备方法和用途 | |
| JPH07233074A (ja) | 皮膚外用組成物 | |
| MICHELSON et al. | Treatment of cutaneous tuberculosis with large doses of vitamin D2 | |
| RU2703735C1 (ru) | Фармацевтическая композиция, содержащая DHMEQ или его аналоги | |
| RU2023444C1 (ru) | Ранозаживляющее средство для местного применения | |
| DE3007226A1 (de) | Arzneikapsel | |
| KIRYATI | The Present Status of the Adrenal Cortical Hormones as Therapeutic Agents in Oral Conditions | |
| EP2883541A1 (en) | Composition for topical use comprising hyaluronic acid | |
| Ghoshal | A Case Report-Chronic Recurrent Traumatic Tongue Ulcer–Modern Treatment Approaches |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |